Identification and characterization of novel
Plasmodium falciparum cyclophilins and their roles in the antimalarial actions of cyclosporin A and derivatives Background Cyclophilins are distributed widely among different organisms and are proposed drug targets for a number of diseases including HIV and hepatitis C infection and ischemia. Cyclophilins play roles in folding and chaperoning of cellular proteins and are the major receptors for the immunosuppressive drug cyclosporin A (CsA). CsA and certain non-immunosuppressive derivatives (e.g., valspodar) possess potent antimalarial activity. We are interested in the role (if any) played by cyclophilins in parasite killing by cyclosporins. We, and others, have previously characterized two CsA-binding cyclophilins (PfCYP19A and PfCYP19B) but a family of genes encoding uncharacterized cyclophilins/cyclophilin-like proteins is also seen in the P. falciparum genome (Figure 1 ).
Results and conclusions
All but three of the cyclophilin/cyclophilin-like genes (or in the case of the larger proteins, their CYP domains) were cloned identically into a pET vector encoding a C-terminal His 6 -tag and eight of them were successfully expressed in Escherichia coli and purified using nickelchelate affinity chromatography. All of the recombinant proteins showed chaperone activity on model substrates, while only PfCYP19A and PfCYP19B demonstrated peptidyl-prolyl isomerase (foldase) activity and were bound by CsA. Our data suggest the existence of a cyclophilintype chaperone family whose partner proteins are not yet known but might include proteins exported to the host erythrocyte. Marin-Menendez and Bell Malaria Journal 2010, 9(Suppl 2):O3 http://www.malariajournal.com/content/9/S2/O3
